| Total cohort (n = 27) | Group A (PEP-Cobb < RPP-Cobb) (n = 13) | Group B (PEP-Cobb > RPP-Cobb) (n = 14) | Statistics | p |
---|---|---|---|---|---|
Gender (f/m) | 20/7 | 10/3 | 10/4 | - | 1.000 a |
Age (years) | 14.30 ± 1.38 | 13.92 ± 1.44 | 14.64 ± 1.28 | t= -1.376 | 0.181 |
Height (m) | 1.63 (1.60, 1.66)b | 1.63 (1.60, 1.65)b | 1.67 ± 0.07 | z = 0.659 | 0.519 |
Weight (kg) | 51.56 ± 12.50 | 47.08 ± 10.59 | 55.71 ± 13.05 | t= -1.876 | 0.072 |
BMI (kg/m2) | 17.85 (16.33, 20.15)b | 17.45 (16.16, 18.64)b | 20.27 ± 4.56 | z = 1.407 | 0.169 |
Disease duration (months) | 12.0(4.5, 18.0)b | 6.0 (2.0, 21.0)b | 12.0 (5.63,15.0) b | z = 0.642 | 0.550 |
HSP-Cobb (°) | 30.59 ± 11.69 | 25.68 ± 8.64 | 35.14 ± 12.57 | t= -2.261 | 0.033* |
Curve type (T%) | 37.0 | 38.5 | 35.7 | - | 1.000 a |
Risser sign | 4.0(2.0, 4.0)b | 4.0(4.0, 4.0)b | 3.5(2.0, 4.0)b | z=-1.047 | 0.295 |